An IPO will make one of the world's richest biopharma families by Angus Liu Thursday, June 13, 2019 After Hansoh Pharma's Hong Kong IPO, its helmswoman Zhong Huijuan and her husband, Jiangsu Hengrui's Sun Piaoyang, will be worth over $16 billion.
Sanofi flu vaccine cleared in Hong Kong after impurities report by Angus Liu Wednesday, January 2, 2019 As tests by Hong Kong's health department and Sanofi showed no quality problems, Sanofi's Vaxigrip has been cleared for use.
HKEX, Zai Lab, WuXi and more—FiercePharmaAsia by Angus Liu Friday, August 31, 2018 Ascletis' stock price slips 44% in a month on HKEX; Zai Lab cans a dermatitis drug licensed from GSK; WuXi names CFO a co-CEO; and more.
FiercePharmaAsia—Takeda-Shire, HKEX and more by Angus Liu Friday, May 11, 2018 Takeda plans major cuts after $62 billion Shire buyout; Ascletis files for HK IPO under new listing rules; AZ hands Seroquel rights to Luye Pharma.
Hong Kong doctor found giving expired flu vaccines to patients by Angus Liu Tuesday, August 22, 2017 Hong Kong’s Department of Health started an investigation after a doctor was found giving expired FluQuadri vaccines to patients.
